These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33467425)

  • 1. Comprehensive Overview of Gene Rearrangements in Childhood T-Cell Acute Lymphoblastic Leukaemia.
    Mroczek A; Zawitkowska J; Kowalczyk J; Lejman M
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia.
    Meijerink JP
    Best Pract Res Clin Haematol; 2010 Sep; 23(3):307-18. PubMed ID: 21112032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute lymphoblastic leukemia.
    Onciu M
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):655-74. PubMed ID: 19577163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOTCH1 mutations are associated with favourable long-term prognosis in paediatric T-cell acute lymphoblastic leukaemia: a retrospective study of patients treated on BCH-2003 and CCLG-2008 protocol in China.
    Gao C; Liu SG; Zhang RD; Li WJ; Zhao XX; Cui L; Wu MY; Zheng HY; Li ZG
    Br J Haematol; 2014 Jul; 166(2):221-8. PubMed ID: 24690100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia.
    La Starza R; Lettieri A; Pierini V; Nofrini V; Gorello P; Songia S; Crescenzi B; Te Kronnie G; Giordan M; Leszl A; Valsecchi MG; Aversa F; Basso G; Biondi A; Conter V; Cazzaniga G; Mecucci C
    Leuk Res; 2013 Aug; 37(8):928-35. PubMed ID: 23735857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-Cell Receptor Rearrangements Determined Using Fragment Analysis in Patients With T-Acute Lymphoblastic Leukemia.
    Kim H; Kim IS; Chang CL; Kong SY; Lim YT; Kong SG; Cho EH; Lee EY; Shin HJ; Park HJ; Eom HS; Lee H
    Ann Lab Med; 2019 Mar; 39(2):125-132. PubMed ID: 30430774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia.
    Van Vlierberghe P; Pieters R; Beverloo HB; Meijerink JP
    Br J Haematol; 2008 Oct; 143(2):153-68. PubMed ID: 18691165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials.
    Eckert C; Parker C; Moorman AV; Irving JA; Kirschner-Schwabe R; Groeneveld-Krentz S; Révész T; Hoogerbrugge P; Hancock J; Sutton R; Henze G; Chen-Santel C; Attarbaschi A; Bourquin JP; Sramkova L; Zimmermann M; Krishnan S; von Stackelberg A; Saha V
    Eur J Cancer; 2021 Jul; 151():175-189. PubMed ID: 34010787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
    Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
    Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood and adolescent lymphoid and myeloid leukemia.
    Pui CH; Schrappe M; Ribeiro RC; Niemeyer CM
    Hematology Am Soc Hematol Educ Program; 2004; ():118-45. PubMed ID: 15561680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma.
    Salmerón-Villalobos J; Ramis-Zaldivar JE; Balagué O; Verdú-Amorós J; Celis V; Sábado C; Garrido M; Mato S; Uriz J; Ortega MJ; Gutierrez-Camino A; Sinnett D; Illarregi U; Carron M; Regueiro A; Galera A; Gonzalez-Farré B; Campo E; Garcia N; Colomer D; Astigarraga I; Andrés M; Llavador M; Martin-Guerrero I; Salaverria I
    Pediatr Blood Cancer; 2022 Nov; 69(11):e29926. PubMed ID: 36000950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell acute lymphoblastic leukaemia: recent molecular biology findings.
    Kraszewska MD; Dawidowska M; Szczepański T; Witt M
    Br J Haematol; 2012 Feb; 156(3):303-15. PubMed ID: 22145858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of T cell receptor beta gene rearrangements and its role in minimal residual disease detection in childhood T-cell acute lymphoblastic leukemia].
    Liu JY; Li ZG; Gao C; Cui L; Wu MY
    Zhonghua Er Ke Za Zhi; 2008 Jul; 46(7):487-92. PubMed ID: 19099802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene mutations and pretransplant minimal residual disease predict risk of relapse in adult patients after allogeneic hematopoietic stem-cell transplantation for T cell acute lymphoblastic leukemia.
    Xu M; Liu H; Liu Y; Ma X; Qiu H; Fu C; Tang X; Han Y; Chen S; Wu D; Sun A
    Leuk Lymphoma; 2019 Nov; 60(11):2744-2753. PubMed ID: 30950667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia.
    Villa-Morales M; Pérez-Gómez L; Pérez-Gómez E; López-Nieva P; Fernández-Navarro P; Santos J
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia.
    Hefazi M; Litzow MR
    Curr Hematol Malig Rep; 2018 Aug; 13(4):265-274. PubMed ID: 29948644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials.
    González-Gil C; Morgades M; Lopes T; Fuster-Tormo F; García-Chica J; Zhao R; Montesinos P; Torrent A; Diaz-Beya M; Coll R; Hermosín L; Mercadal S; González-Campos J; Zamora L; Artola T; Vall-Llovera F; Tormo M; Gil-Cortés C; Barba P; Novo A; Ribera J; Bernal T; De Ugarriza PL; Queipo MP; Martínez-Sánchez P; Giménez A; González-Martínez T; Cladera A; Cervera J; Fernández-Martín R; Ardaiz MÁ; Vidal MJ; Baena Á; López-Bigas N; Bigas A; Maciejewski J; Orfao A; Ribera JM; Genescà E
    Haematologica; 2023 Apr; 108(4):969-980. PubMed ID: 36325893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New advances in targeting aberrant signaling pathways in T-cell acute lymphoblastic leukemia.
    Paganelli F; Lonetti A; Anselmi L; Martelli AM; Evangelisti C; Chiarini F
    Adv Biol Regul; 2019 Dec; 74():100649. PubMed ID: 31523031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.
    Coustan-Smith E; Mullighan CG; Onciu M; Behm FG; Raimondi SC; Pei D; Cheng C; Su X; Rubnitz JE; Basso G; Biondi A; Pui CH; Downing JR; Campana D
    Lancet Oncol; 2009 Feb; 10(2):147-56. PubMed ID: 19147408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols.
    Paganin M; Grillo MF; Silvestri D; Scapinello G; Buldini B; Cazzaniga G; Biondi A; Valsecchi MG; Conter V; Te Kronnie G; Basso G
    Br J Haematol; 2018 Sep; 182(5):705-711. PubMed ID: 29938780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.